02228 QUANTUMPH-P
QUANTUMPH-P
QUANTUMPH-P
| Listing Date | 2024/06/13 |
| Listing Price | 5.280 |
Subscription Result
- Subscription Rate103.35x
- Guarantee One Lot Size15 lot
- One Lot Success Rate20%
|
|
|
|
|
|
|
|
|
|
IPO Detail
COMPANY PROFILE
QuantumPharm Inc. is a quantum physics-based, AI-powered, and robotics-driven, innovative R&D platform. It adopts a combination of quantum physics-based first-principles calculation, AI, high performance cloud computing, and scalable and standardized robotic automation to provide drug and material science R&D solutions and services to global and domestic companies in the pharmaceutical and material science including agritech, energy and new chemicals, and cosmetics industries and beyond.
--
The Group’s business primarily comprises drug discovery solutions providing modular solutions spanning the full spectrum of the drug discovery and research process, and intelligent automation solutions consisting primarily of solid-state R&D services and automated chemical synthesis services.
--
The Group’s customer base includes 16 of the top 20 global biotechnology and pharmaceutical companies ranked by revenue in 2022 according to report. As of December 31, 2023, it also had more than 160 granted patents, approximately 39 ongoing drug discovery programs, and four R&D facilities with more than 10,000 sq.m. of lab space.
BASIC INFORMATION
| Market | Hong Kong (Main Board) |
| Business Nature | Health Care |
| Major Business Area | China |
| Board Lot | 1000 |
GLOBAL OFFERING
| No. of Offer Shares | 187.37M shares |
| No. of International Offer Shares | 149.90M shares |
| No. of HK Offer Shares | 37.48M shares |
| Offer Price | $5.03 - $6.03 |
| Stock Code | 2228 |
| Sponsor(s) | CITIC Securities (Hong Kong) Limited |
| Underwriter(s) | CLSA Limited, China International Capital Corporation Hong Kong Securities Limited, Jefferies Hong Kong Limited, Deutsche Bank AG, Hong Kong Branch, CMB International Capital Limited, SPDB International Capital Limited, Guosen Securities (HK) Capital Company Limited, Fosun International Securities Limited, ABCI Securities Company Limited, BOCI Asia Limited, CCB International Capital Limited, ICBC International Securities Limited, Futu Securities International (Hong Kong) Limited, Livermore Holdings Limited, TradeGo Markets Limited |
TIME TABLE
| Application Period | Jun 04 (Tue) - noon, Jun 07 (Fri) |
| Price Determination Date | Jun 11 (Tue) |
| Result Announcement Date | On or before Jun 12 (Wed) |
| Result Announcement Date | On or before Jun 12 (Wed) |
| Result Announcement Date | On or before Jun 13 (Thu) |
| Dealings in Shares commence on | Jun 13, 2024. (Thu) |
Reallocation of Shares Offered
| Times of HK Offer Shares Subscription | 10X - 50X | Over 50X |
| % of total shares reallocated to HK Offer | 10% | 20% |
Sales Statistics (HKD)
| Offer Price | $5.03 - $6.03 |
| Capitalization | 17.14B - 20.54B |
| NAV / share ($) | $1.52 - $1.58 (Unaudited pro forma adj NAV / share) |
Use Of Proceeds
| Assuming the offer price being at HKD 5.53, the net proceeds raised would be HKD 941.10M, of which |
| 75% : To continuously enhance R&D capabilities and solutions provision |
| 15% : To improve commercialization capability in and beyond China |
| 10% : Working capital |
Related Document
| Prospectus |  Chinese Version | English Version |
| Remark： | The above information is referenced from the prospectus. |
| All data is calculated from the non- exercise rights(if applicable). |
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --Offer Price︰--
| Currency | : |
| Listing Price | : |
| Board Lot | : |
| Admission Fee* |
: |
| Subscribing Lot | : |
| Subscribing Fee | : |
| Subscribing Amount | : |
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).